Benchmark reiterated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a research report released on Thursday morning,Benzinga reports. The brokerage currently has a ...

NASA’s ambitious Artemis program is making steady progress toward its goal of establishing a long-term human presence on the ...

This week gave us a rare opportunity to discuss Windows Phone, Windows 95, and the shifting Surface lineup from Microsoft.